Synergistic antitumor activity of taxol and immunotoxin SS1P in tumor-bearing mice
- PMID: 16899620
- DOI: 10.1158/1078-0432.CCR-06-0346
Synergistic antitumor activity of taxol and immunotoxin SS1P in tumor-bearing mice
Abstract
Purpose: To investigate the combined antitumor activity in mice of immunotoxin SS1P and Taxol.
Methods: Immunodeficient mice were implanted with A431/K5 tumors expressing mesothelin. Established tumors were treated i.v. with immunotoxin SS1P alone, i.p. with Taxol alone, or with the two agents together. SS1P was radiolabeled with (111)In and used to study the effect of Taxol on its uptake by A431/K5 tumors.
Results: Using doses at which either agent alone caused stabilization of tumor growth, the combination was synergistic causing long-lasting complete remissions in many animals. In contrast, synergy was not observed when the same cells were treated with these agents in vitro. Tumor uptake of (111)In-SS1P was not affected by treatment with Taxol.
Conclusion: The combination of Taxol and SS1P exerts a synergistic antitumor effect in animals but not in cell culture. This effect is not secondary to increased tumor uptake of the immunotoxin. Synergy could be due to improved immunotoxin distribution within the tumor or could involve factors released by other cell types in the tumors.
Similar articles
-
Anti-mesothelin immunotoxin SS1P in combination with gemcitabine results in increased activity against mesothelin-expressing tumor xenografts.Clin Cancer Res. 2007 Dec 1;13(23):7166-71. doi: 10.1158/1078-0432.CCR-07-1592. Clin Cancer Res. 2007. PMID: 18056197
-
Immunotoxin and Taxol synergy results from a decrease in shed mesothelin levels in the extracellular space of tumors.Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17099-104. doi: 10.1073/pnas.0708101104. Epub 2007 Oct 16. Proc Natl Acad Sci U S A. 2007. PMID: 17940013 Free PMC article.
-
Tumor-directed radiation and the immunotoxin SS1P in the treatment of mesothelin-expressing tumor xenografts.Clin Cancer Res. 2006 Aug 15;12(16):4983-8. doi: 10.1158/1078-0432.CCR-06-0441. Clin Cancer Res. 2006. PMID: 16914588
-
Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice.Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3444-51. doi: 10.1158/1078-0432.CCR-05-2823. Clin Cancer Res. 2006. PMID: 16740769
-
Releasable PEGylation of mesothelin targeted immunotoxin SS1P achieves single dosage complete regression of a human carcinoma in mice.Bioconjug Chem. 2007 May-Jun;18(3):773-84. doi: 10.1021/bc060314x. Epub 2007 Mar 9. Bioconjug Chem. 2007. PMID: 17346030
Cited by
-
Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles.ACS Nano. 2015;9(4):3740-52. doi: 10.1021/acsnano.5b00929. Epub 2015 Apr 6. ACS Nano. 2015. PMID: 25831471 Free PMC article.
-
Mesothelin as a potential therapeutic target in human cholangiocarcinoma.J Cancer. 2010 Oct 1;1:141-9. doi: 10.7150/jca.1.141. J Cancer. 2010. PMID: 20922056 Free PMC article.
-
Phase 1 study of the antimesothelin immunotoxin SS1P in combination with pemetrexed and cisplatin for front-line therapy of pleural mesothelioma and correlation of tumor response with serum mesothelin, megakaryocyte potentiating factor, and cancer antigen 125.Cancer. 2014 Nov 1;120(21):3311-9. doi: 10.1002/cncr.28875. Epub 2014 Jul 2. Cancer. 2014. PMID: 24989332 Free PMC article. Clinical Trial.
-
Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis.Nat Commun. 2015 Mar 11;6:6536. doi: 10.1038/ncomms7536. Nat Commun. 2015. PMID: 25758784 Free PMC article.
-
Combined-modality radioimmunotherapy: synergistic effect of paclitaxel and additive effect of bevacizumab.Nucl Med Biol. 2012 May;39(4):472-83. doi: 10.1016/j.nucmedbio.2011.10.020. Epub 2011 Dec 14. Nucl Med Biol. 2012. PMID: 22172384 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials